Epigenetic Editing Potentially Lowers Cholesterol Levels Permanently

Scientists have presented the results of a remarkable preclinical study that employs an epigenetic approach instead of traditional gene editing. In this method, DNA sequences are not cut and replaced — instead, scientists merely adjust the activity of specific genes. This treatment has already led to the normalization of cholesterol levels in mice. Epigenetic editing…

Read More

The integrated AMD Radeon 800M RDNA 3.5 graphics in the 3DMark Time Spy benchmark is approaching the performance of the RTX 2050

A new leak about the integrated graphics processor AMD RDNA 3.5 “Radeon 800M” was provided by Golden Pig Upgrade. The source detailed the information, claiming that tests on MSI laptops with Ryzen AI 300 processors at Computex 2024 show that the new generation iGPU significantly outperforms its predecessors—RDNA 3 “Radeon 700M.” The MSI laptop models…

Read More

A silk fabric has been developed that completely suppresses sound up to 65 dB

Undesirable sounds accompany residents of large cities round the clock, from traffic noise outside to the murmuring of a television behind the wall. This constant exposure to noise leads to increased fatigue, nervousness, and illness among us. To reduce noise pollution, specialists from the USA have developed sound-absorbing fabric no thicker than a human hair,…

Read More

A new photonic chip processes 100 billion pixels in 6 nanoseconds

Machine vision is a rapidly developing field in robotics, integrating cameras, sensors, and algorithms into systems for capturing and analyzing images. Modern conditions require that collected data be processed as quickly as possible, ideally within the device itself—whether in a smartphone, laptop, or car. For such edge computing needs, specialists from Tsinghua University in China…

Read More

The first combined vaccine against influenza and COVID-19 has been developed

Scientists at the pharmaceutical company Moderna have developed the first mRNA vaccine targeting both influenza and coronavirus. This combined vaccine successfully completed Phase 3 clinical trials and is awaiting approval from the US regulator FDA. According to Nature, the combined vaccine has shown higher efficacy compared to monovalent vaccines targeting only one virus. mRNA technology…

Read More